Hopfner Robert Lorne

FollowCreate a free account to set a filing alert.

Director at Evommune, Inc. · on record since Dec 22, 2025
10% owner at Evommune, Inc. · on record since Dec 22, 2025
Director at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
Director at Vaxcyte, Inc. · on record since Jun 16, 2020
Director at Inozyme Pharma, Inc. · on record since Jul 28, 2020
10% owner at Inozyme Pharma, Inc. · on record since Jul 28, 2020
Director at Rallybio Corp · on record since Jul 29, 2021

Insider trading activity of Hopfner Robert Lorne

Transactions on record: 98; since Jun 15, 2020

Purchases: 12; $25.2M

Sales: 40; $22M

Companies traded: 4; last filing Oct 14, 2026

Figures computed from official regulatory filings — .

Companies where Hopfner Robert Lorne has traded

Rallybio Corp16 tx · $7.7M · Oct 14, 2026
Evommune, Inc.15 tx · $17.4K · Dec 22, 2025
Inozyme Pharma, Inc.18 tx · $34.2M · Jul 3, 2025
Vaxcyte, Inc.49 tx · $23.5M · Jun 3, 2021

Track record of Hopfner Robert Lorne

Statistical track record

Free account

Purchases: 12

Last buy: Dec 19, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Hopfner Robert Lorne

Co-insiders of Hopfner Robert Lorne

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Rallybio CorpListing on record	Oct 14, 2026	Exercise	9,196	7.60 USD	$69.9K		SEC
Rallybio CorpListing on record	Oct 14, 2026	ExerciseD (derivative)	-3,562	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Rallybio CorpListing on record	Oct 14, 2026	Exercise	3,562	2.38 USD	$8.5K		SEC
Rallybio CorpListing on record	Oct 14, 2026	ExerciseD (derivative)	-9,196	0.56 USD	$5.1K		SEC
Rallybio CorpListing on record	Oct 14, 2026	Exercise	2,062	15.28 USD	$31.5K		SEC
Rallybio CorpListing on record	Oct 14, 2026	ExerciseD (derivative)	-2,062	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evommune, Inc.Listing unverified	Dec 22, 2025	Buy	1,000	17.35 USD	$17.4K	conv 49ClusterFirst in 12mo	SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-1,895,260	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-7,230,283	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-2,582,243	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	Other	3,026	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-25,790	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-2,104,740	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-7,145,647	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	Other	1,632,441	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	Other	1,441,032	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	Other	294,502	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-3,572,816	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-2,508,575	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-313,571	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-313,571	—	n/a (No price was disclosed in the filing)		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 3, 2025	Other	-2,923,110	4.00 USD	$11.7M		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 3, 2025	Other	-1,571,741	4.00 USD	$6.3M		SEC
Rallybio CorpListing on record	May 15, 2025	AwardD (derivative)	28,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Rallybio CorpListing on record	Jan 6, 2025	AwardD (derivative)	73,571	0.70 USD	$51.5K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Rallybio CorpListing on record	Oct 14, 2026	Exercise	9,196	7.60 USD	$69.9K		SEC
Rallybio CorpListing on record	Oct 14, 2026	ExerciseD (derivative)	-3,562	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Rallybio CorpListing on record	Oct 14, 2026	Exercise	3,562	2.38 USD	$8.5K		SEC
Rallybio CorpListing on record	Oct 14, 2026	ExerciseD (derivative)	-9,196	0.56 USD	$5.1K		SEC
Rallybio CorpListing on record	Oct 14, 2026	Exercise	2,062	15.28 USD	$31.5K		SEC
Rallybio CorpListing on record	Oct 14, 2026	ExerciseD (derivative)	-2,062	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evommune, Inc.Listing unverified	Dec 22, 2025	Buy	1,000	17.35 USD	$17.4K	conv 49ClusterFirst in 12mo	SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-1,895,260	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-7,230,283	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-2,582,243	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	Other	3,026	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-25,790	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-2,104,740	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-7,145,647	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	Other	1,632,441	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	Other	1,441,032	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	Other	294,502	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-3,572,816	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-2,508,575	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-313,571	—	n/a (No price was disclosed in the filing)		SEC
Evommune, Inc.Listing unverified	Nov 12, 2025	OtherD (derivative)	-313,571	—	n/a (No price was disclosed in the filing)		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 3, 2025	Other	-2,923,110	4.00 USD	$11.7M		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 3, 2025	Other	-1,571,741	4.00 USD	$6.3M		SEC
Rallybio CorpListing on record	May 15, 2025	AwardD (derivative)	28,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Rallybio CorpListing on record	Jan 6, 2025	AwardD (derivative)	73,571	0.70 USD	$51.5K		SEC